Description

13,33,332 equity shares of Vivo Bio tech Ltd. (Scrip Code 511509) issued at Rs. 45/- on preferential basis to Non-Promoters will be listed and permitted to trade on BSE from October 13, 2025.

Summary

BSE has announced the listing of 13,33,332 new equity shares of Vivo Bio tech Ltd. (Scrip Code: 511509) on October 13, 2025. These shares were issued at a premium of Rs. 35/- per share (issue price Rs. 45/-) to Non-Promoters on a preferential basis pursuant to conversion of warrants. The allotment date was August 12, 2025, and all shares are subject to lock-in until April 30, 2025.

Key Points

  • Company: Vivo Bio tech Ltd. (Scrip Code: 511509)
  • Number of Shares: 13,33,332 equity shares of Rs. 1/- each
  • Issue Type: Preferential allotment to Non-Promoters (warrant conversion)
  • Issue Price: Rs. 45/- per share (Rs. 1/- face value + Rs. 35/- premium)
  • Distinctive Numbers: 19999890 to 21333221
  • ISIN: INE380K01017
  • Trading Start Date: Monday, October 13, 2025
  • Ranking: Pari-passu with existing equity shares

Regulatory Changes

No regulatory changes. This is a standard listing circular for new securities.

Compliance Requirements

  • Trading members must note the listing of these new securities for trading operations from October 13, 2025
  • All 13,33,332 shares (Dist. Nos. 19999890 to 21333221) are subject to lock-in until April 30, 2025
  • These shares carry the same rights and privileges as existing equity shares

Important Dates

  • Allotment Date: August 12, 2025
  • Trading Commencement: Monday, October 13, 2025
  • Lock-in Period Ends: April 30, 2025

Impact Assessment

This is a routine listing announcement with minimal market impact. The preferential allotment represents a warrant conversion to Non-Promoters, adding 13.33 lakh shares to the traded stock. The lock-in period until April 30, 2025 ensures these shares cannot be sold immediately, limiting short-term supply pressure. The shares rank pari-passu with existing equity, maintaining uniform shareholder rights. Trading members should update their systems to reflect the expanded share capital and distinctive number range.

Impact Justification

Routine listing of preferential allotment shares from warrant conversion. Limited market impact due to small issue size and lock-in period.